Related Experiment Video
Updated: Jul 7, 2026

10:24
SILAC Based Proteomic Characterization of Exosomes from HIV-1 Infected Cells
Published on: March 3, 2017
Cellular proteins detected in HIV-1
1AIDS Vaccine Program, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD 21702-1201, USA. ott@ncifcrf.gov
Reviews in Medical Virology
|February 12, 2008
Summary
Human immunodeficiency virus type 1 (HIV-1) virions contain numerous host proteins. Understanding these cellular proteins
Area of Science:
- Virology and Immunology
- Molecular Biology
- Cellular Biology
Background:
- Human immunodeficiency virus type 1 (HIV-1) virions are known to incorporate cellular proteins alongside viral-encoded proteins.
- Recent research has significantly expanded the catalog of host proteins identified within HIV-1 particles.
Purpose of the Study:
- To review current findings on cellular proteins present in HIV-1 virions.
- To summarize functional studies investigating the roles of these host proteins in viral replication, pathogenesis, and host immune response.
- To highlight the potential of viral-host protein interactions as targets for anti-HIV therapies and to deepen understanding of HIV-1's impact on the immune system.
Main Methods:
- Review of existing scientific literature and recent studies.
- Biochemical characterization of HIV-1 virions.
- Analysis of functional studies on identified cellular proteins.
Main Results:
- A substantial number of host cellular proteins have been identified in HIV-1 virions.
- These cellular proteins may play significant roles in the HIV-1 replication cycle and disease progression.
- Interactions between viral and cellular proteins offer potential therapeutic targets and insights into HIV-1's immunomodulatory effects.
Conclusions:
- The comprehensive study of HIV-1's interaction with host proteins provides critical insights into viral biology, immunology, and vaccine science.
- Understanding these viral-cellular protein interactions can illuminate fundamental cellular pathways.
- Targeting these interactions may lead to novel therapeutic strategies against HIV-1.

